Non-Interventional Studies

Non-Interventional Studies(NIS)

Assess short and long-term treatment patterns to understand the effectiveness, safety, use, and value of your product.
Non-Interventional Studies Research

Observational research enables long-term evaluation and generates evidence to define, substantiate, and communicate the value of your treatment to different stakeholders.

We’re proud to offer decades of experience in observational and non-interventional research studies. This allows us to be fully adaptive when realizing your product’s value.

Our treatment value experts understand the varied needs of patients, payers and healthcare professionals, as well as regulatory requirements. We’ll help you demonstrate your treatment's value for these audiences by identifying the actions needed to maximize your treatment's potential before launch and after approval, and minimize the possible risks.

Client Results

30+ years

Of experience as a contract research organization (CRO). Our team consists of specialists in non-interventional research as well as a global network of healthcare personnel. We have conducted more than 500 non-interventional studies covering over 2 million patients.

1500+ studies

We’ve published over 1500 studies covering over 200 conditions, with a special focus on oncology and rare diseases.

Depth

Research is supported by a full-service, global clinical operations team that is highly experienced in study design, taking into consideration study objectives, protocol development, country-specific regulatory requirements, data analytics, and reporting.

Standards

We are ISO 20252 and 27001 certified and meet GCP, GEP, GPP, and ENCePP requirements. Our proprietary electronic data capture (EDC) applications assure high-quality data collection, data cleaning, and data validation that fulfill European Medicines Agency (EMA) and Food and Drug Administration (FDA) regulatory requirements.

Networks

Clients benefit from our extensive partnerships and relationships with global networks, academia and scientific committees, advocacy groups, and patient associations.